Title : Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer.

Pub. Date : 2009 Nov 20

PMID : 19826113






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cediranib is an oral tyrosine kinase inhibitor (TKI) of vascular endothelial growth factor receptor (VEGFR) -1, VEGFR-2, VEGFR-3, and c-kit. cediranib fms related receptor tyrosine kinase 1 Homo sapiens